Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
C.
Show more
Class 5: human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness
Class 42: research in the field of cellular assay screening and pharmaceutical discovery and development
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 10 Mar 2022Application filedNew Application Entered
- 17 Dec 2022Assigned to an examining attorneyAssigned To Examiner
- 19 Dec 2022Approved for publicationApproved For Pub - Principal Register
- 24 Jan 2023Published for oppositionPublished For Opposition
- 21 Mar 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 7 Sep 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 12 Mar 2024Statement-of-use extension 2 grantedSou Extension 2 Granted
- 20 Aug 2024Statement-of-use extension 3 grantedSou Extension 3 Granted
- 20 Aug 2024Statement of use filedTeas Statement Of Use Received
- 23 Nov 2024Office action issuedNon-Final Action Written
- 12 Feb 2025Response to office action filedTeas Response To Office Action Received
- 20 Feb 2025Statement of use acceptedAllowed Principal Register - Sou Accepted
- 11 Mar 2025Registered on the Principal RegisterRegistered-Principal Register
All 39 events
| 2025-03-11 | Registered-Principal Register |
| 2025-03-11 | Notice Of Registration Confirmation Emailed |
| 2025-02-20 | Assigned To Lie |
| 2025-02-20 | Correspondence Received In Law Office |
| 2025-02-20 | Teas/Email Correspondence Entered |
| 2025-02-20 | Allowed Principal Register - Sou Accepted |
| 2025-02-20 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2025-02-12 | Teas Response To Office Action Received |
| 2024-11-23 | Non-Final Action Written |
| 2024-11-23 | Non-Final Action E-Mailed |
| 2024-11-23 | Notification Of Non-Final Action E-Mailed |
| 2024-11-22 | Divisional Processing Complete |
| 2024-11-22 | Statement Of Use Processing Complete |
| 2024-10-24 | Case Assigned To Intent To Use Paralegal |
| 2024-08-20 | Sou Teas Extension Received |
| 2024-08-20 | Sou Extension 3 Filed |
| 2024-08-20 | Sou Extension 3 Granted |
| 2024-08-20 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-08-20 | Teas Statement Of Use Received |
| 2024-08-20 | Teas Request To Divide Received |
| 2024-08-20 | Divisional Request Received |
| 2024-08-20 | Use Amendment Filed |
| 2024-03-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-03-12 | Sou Teas Extension Received |
| 2024-03-12 | Sou Extension 2 Filed |
| 2024-03-12 | Sou Extension 2 Granted |
| 2023-09-09 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-09-07 | Sou Teas Extension Received |
| 2023-09-07 | Sou Extension 1 Filed |
| 2023-09-07 | Sou Extension 1 Granted |
| 2023-03-21 | Noa Mailed - Sou Required From Applicant |
| 2023-01-24 | Published For Opposition |
| 2023-01-24 | Official Gazette Publication Confirmation E-Mailed |
| 2023-01-04 | Notification Of Notice Of Publication E-Mailed |
| 2022-12-19 | Approved For Pub - Principal Register |
| 2022-12-17 | Assigned To Examiner |
| 2022-03-12 | Notice Of Design Search Code E-Mailed |
| 2022-03-11 | New Application Office Supplied Data Entered |
| 2022-03-10 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness
First use anywhere 5 Jun 2023 · First use in commerce 5 Jun 2023
Class 42 Technology & SaaS
research in the field of cellular assay screening and pharmaceutical discovery and development
First use anywhere 0 Sep 2015 · First use in commerce 0 Sep 2015
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 11 Mar 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.